Par Drugs & Chemicals Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Sep 2025 is 10.02% vs 16.66% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 24.02% vs 101.82% in Jun 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 70.51% vs 46.50% in Jun 2025

Interest

QoQ Growth in quarter ended Sep 2025 is 150.00% vs 0.00% in Jun 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Par Drugs & Che. With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

28.66

15.32

13.34

87.08%

Other Operating Income

0.00

Total Operating income

28.66

15.32

13.34

87.08%

Raw Material Cost

10.54

11.33

-0.79

-6.97%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.18

0.00

0.18

Employee Cost

1.35

1.43

-0.08

-5.59%

Power Cost

0.00

Manufacturing Expenses

0.00

-0.01

0.01

100.00%

Selling and Distribution Expenses

0.00

Other Expenses

10.52

1.81

8.71

481.22%

Total Expenditure (Excl Depreciation)

22.59

14.56

8.03

55.15%

Operating Profit (PBDIT) excl Other Income

6.07

0.76

5.31

698.68%

Other Income

0.48

0.53

-0.05

-9.43%

Operating Profit (PBDIT)

6.55

1.29

5.26

407.75%

Interest

0.05

0.10

-0.05

-50.00%

Exceptional Items

0.00

Gross Profit (PBDT)

6.50

1.19

5.31

446.22%

Depreciation

0.94

0.23

0.71

308.70%

Profit Before Tax

5.55

0.96

4.59

478.12%

Tax

1.42

0.24

1.18

491.67%

Provisions and contingencies

0.00

Profit After Tax

4.13

0.72

3.41

473.61%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

4.13

0.72

3.41

473.61%

Equity Capital

12.30

10.24

2.06

20.12%

Face Value

10.00

2.00

0.00

Reserves

94.13

0.00

94.13

Earnings per share (EPS)

3.36

0.14

3.22

2,300.00%

Diluted Earnings per share

3.36

0.14

3.22

2,300.00%

Operating Profit Margin (Excl OI)

21.18%

4.96%

0.00

16.22%

Gross Profit Margin

22.68%

7.77%

0.00

14.91%

PAT Margin

14.41%

4.70%

0.00

9.71%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 28.66 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 10.02% vs 16.66% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -17.31% vs 33.87% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 4.13 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 24.02% vs 101.82% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -51.98% vs 75.87% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 6.07 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 70.51% vs 46.50% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -46.80% vs 54.82% in Sep 2024

Quarterly - Interest

Interest 0.05 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 150.00% vs 0.00% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 66.67% vs 0.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 21.18%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024